<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03398317</url>
  </required_header>
  <id_info>
    <org_study_id>GFC - 002</org_study_id>
    <nct_id>NCT03398317</nct_id>
  </id_info>
  <brief_title>Sperm Selection by Either PICSI or MACS in Cases With Abnormal Sperm DNA Fragmentation Index for ICSI</brief_title>
  <official_title>Sperm Selection by Either PICSI or MACS in Cases With Abnormal Sperm DNA Fragmentation Index for ICSI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ganin Fertility Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of the Western Cape</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ganin Fertility Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      On the day of ICSI, choosing the best sperm by either PICSI or magnetic activated cell
      sorting (MACS) in cases with abnormal DNA is not fully investigated. This study helps in
      solving this problem by using two known techniques to achieve that purpose.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sperm DNA fragmentation has shown a negative correlation with fertilization rate, embryo
      quality, and implantation rate. And a positive correlation with miscarriage rate in the 1st
      trimester.

      Sperm selection methods like PICSI and MACS have been developed for selecting a healthy
      mature non apoptotic sperm with healthy membrane for Oocyte injection so as to obtain best
      embryo quality and achieve higher ongoing pregnancy rates.

      A sperm selection technique based on sperm membrane binding to hyaluronic acid (PICSI Dish),
      the main substrate of the oocyte zonapellucida, could improve the likelihood of obtaining
      better sperm for ICSI with non fragmented DNA. Another sperm selection technique based on
      Magnetic activated cell sorting (MACS) that depends on the binding of protein Annexin V to
      phosphatidylserine which is a marker for apoptosis, giving a resulting (eluted) spermatozoa
      without DNA fragmentation.

      In order to determine which sperm selection technique is better for dealing with DNA
      fragmentation patients we need to study both techniques on two different groups of patients
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">March 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>20 weeks of gestation</time_frame>
    <description>Defined as the proportion of pregnancies that completed more than 20 weeks of gestation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of cleavage rate</measure>
    <time_frame>3 days</time_frame>
    <description>Defined as the proportion of cleaved embryos on day 3 over the injected oocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Blastulation rate</measure>
    <time_frame>5-6 days</time_frame>
    <description>Defined as the proportion of blastocysts formed on day 5 or 6 over the cleaved embryos on day 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Blastocyst quality rate</measure>
    <time_frame>5-6 days</time_frame>
    <description>Defined as the assessment of blastocyst quality according to Gardner's criteria into: good, fair or bad in terms of percentage of the total formed blastocysts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Pregnancy rate</measure>
    <time_frame>14 days following embryo transfer</time_frame>
    <description>Defined as clinical pregnancy per transfer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of implantation rate</measure>
    <time_frame>6- 8 weeks following embryo transfer</time_frame>
    <description>Defined as number of gestational sacs with fetal heart beat, shown by ultrasound in gestational week 6 over number of embryo transferred.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Sperm DNA Fragmentation</condition>
  <arm_group>
    <arm_group_label>PICSI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Semen processing is done by double layer density gradient method followed by adding Sperm to the dot of hyaluronan on the PICSI dish, within minutes the bound sperm are attached by their acrosome to the surface of the dot. Selecting an individual bound sperm with enhanced genetic and developmental integrity ensures that the sperm selected is the optimal sperm from the sample for oocyte injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MACS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Semen processing is done by double layer density gradient method. The resulted pellet is labeled with annexin V microbeads followed by separation on MACS Column, the eluted fraction contains non apoptotic sperm suitable for Oocyte injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PICSI</intervention_name>
    <description>sperm selection using PICSI dish for selecting sperm with lower DNA fragmentation index</description>
    <arm_group_label>PICSI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MACS</intervention_name>
    <description>sperm selection using MACS for selecting sperm with lower DNA fragmentation index</description>
    <arm_group_label>MACS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males diagnosed of abnormal DNA fragmentation index ( &gt; 19%).

          -  Males with mild to moderate OTA (oligoteratoasthenozoospermia).

          -  Male aged 18-60 years.

          -  Female aged 18-40 years.

          -  Normo responder ( &gt; 5 mature oocytes)

          -  Male will have to refrain from ejaculation no less than 1 day but no greater than 3
             days prior semen specimen production on day of oocyte retrieval

        Exclusion Criteria:

        Males with normalDNA fragmentation index (&lt;19%)at the initial assessment.

          -  Leukocytospermia

          -  Presence of varicocele.

          -  Known genetic abnormality

          -  Use of sperm donation or cryopreserved sperm

          -  Use of Oocyte donation

          -  Use of gestational carrier

          -  Presence of any of the endometrial factors that affect embryo implantation such as
             hydrosalpings, adenomyosis or previous uterine infection

          -  Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hosam Zaki, MSc, FRCOG</last_name>
    <role>Study Chair</role>
    <affiliation>Ganin Fertility Center, Cairo, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eman Hasanen, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ganin Fertility Center, Cairo, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Khaled El Qusi, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ganin Fertility Center, Cairo, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abd El Ghafar Hussin, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ganin Fertility Center, Cairo, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salma El Tanbouly, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ganin Fertility Center, Cairo, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ashok Agarwal, PhD</last_name>
    <role>Study Director</role>
    <affiliation>American Center of Reproductive Medicine, Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ralph Henkel, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of the Western Cape</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hanaa El Khedr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ganin Fertility Center, Cairo, Egypt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hosam Zaki, MSc, FRCOG</last_name>
    <phone>00201222150018</phone>
    <email>hosamz@tedata.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eman Hasanen, BSc</last_name>
    <phone>00201282012291</phone>
    <email>em.saberh@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ganin Fertility Center</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hosam Zaki, MSc, FRCOG</last_name>
      <phone>00201222150018</phone>
      <email>hosamz@teadata.net.eg</email>
    </contact>
    <contact_backup>
      <last_name>Eman Hasanen, BSc</last_name>
      <phone>00201282012291</phone>
      <email>em.saberh@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Benchaib M, Braun V, Lornage J, Hadj S, Salle B, Lejeune H, Gu√©rin JF. Sperm DNA fragmentation decreases the pregnancy rate in an assisted reproductive technique. Hum Reprod. 2003 May;18(5):1023-8.</citation>
    <PMID>12721180</PMID>
  </reference>
  <reference>
    <citation>Baldi and Muratori (2013) Genitic Damage in Human Spermatozoa. USA, NY : Springer Science &amp; Business Media.</citation>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2018</study_first_submitted>
  <study_first_submitted_qc>January 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2018</study_first_posted>
  <last_update_submitted>January 7, 2018</last_update_submitted>
  <last_update_submitted_qc>January 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ganin Fertility Center</investigator_affiliation>
    <investigator_full_name>Eman Hasanen</investigator_full_name>
    <investigator_title>Clinical Embryologist</investigator_title>
  </responsible_party>
  <keyword>SDF</keyword>
  <keyword>DFI</keyword>
  <keyword>sperm selection</keyword>
  <keyword>PICSI</keyword>
  <keyword>MACS</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

